Description

History / Background

AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) is a synthetic analog of adenosine monophosphate (AMP) and acts as a potent activator of AMP-activated protein kinase (AMPK)—a key enzyme responsible for regulating cellular energy balance.

Originally developed for the treatment of metabolic disorders, cardiovascular disease, and muscle-wasting conditions, AICAR has since gained attention in exercise physiology and sports science for its potential performance-enhancing effects.

By activating AMPK, AICAR supports increased glucose uptake, enhanced fatty acid oxidation, and improved cellular energy efficiency. Research has focused on its ability to influence endurance capacity, fat metabolism, and overall metabolic health.

Benefits

The potential benefits of AICAR include:

Increased Endurance
AICAR may enhance endurance performance by promoting fat utilization for energy and supporting mitochondrial biogenesis—leading to improved stamina and physical output.
Fat Loss
Through AMPK activation, AICAR increases fatty acid oxidation, which can support fat loss and improved body composition.
Improved Muscle Metabolism
AICAR may enhance glucose uptake in muscle cells, increasing cellular energy availability and aiding exercise performance and recovery.
Potential Cardiovascular Benefits
Some research suggests AICAR may improve blood flow and reduce inflammation, contributing to cardiovascular health.
Metabolic Regulation
AMPK activation plays a key role in regulating metabolic processes. AICAR may benefit individuals with insulin resistance, metabolic syndrome, or impaired metabolic function.

Recommended Dosage

AICAR is not approved for medical use, and no official dosage guidelines exist. Research-based and anecdotal information suggests the following:

Administration: Typically delivered via subcutaneous injection or intravenous infusion in research settings.
Common Research Dosage: Studies often use 10–20 mg per kilogram of body weight, though formulations and goals may vary.

Because AICAR is a research chemical, dosing for personal use is neither standardized nor medically endorsed.

Important Considerations

• Regulatory Status

AICAR is not FDA-approved or approved by other major regulatory agencies for human use. It remains classified strictly as a research chemical.

• Doping Concerns

AICAR is listed on the World Anti-Doping Agency (WADA) prohibited substances list due to its performance-enhancing potential. Competitive athletes should avoid its use to comply with doping regulations.

• Safety and Side Effects

The safety profile of AICAR is not well-established. Reported or potential side effects may include:

nausea
headaches
gastrointestinal discomfort

Long-term safety data is limited, and risks remain unclear.

• Consultation with Healthcare Professionals

Anyone considering the use of AICAR should consult a qualified healthcare professional. Given its unregulated status and uncertain safety profile, caution is strongly advised.